Novartis Pharma Ag - Significant Ownership

Signature - Title
/s/ Christian Rehm - Christian Rehm / Authorised Signatory
Location
Basel, Switzerland
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Novartis Pharma Ag.

Significant Ownership of Novartis Pharma Ag

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ERAS Erasca, Inc. Common stock, par value $0.0001 per share 4.4% $14.9M 12.3M Novartis Pharma AG Dec 31, 2024
DTIL PRECISION BIOSCIENCES INC Common stock, par value $0.000005 per share 3.7% $2.12M 414K 0% Novartis Pharma AG Jun 30, 2025

Schedules 13D/G Reported by Novartis Pharma Ag:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.